ISSN (Online) - 2349-8846
-A A +A
Affordability and Drug Market Segmentation

Thrombolytic Treatment for Myocardial Infarction

All authors were formerly at Council of Scientific and Industrial Research HQ, New Delhi. This study looks at the available life-saving treatments for heart attacks and ischaemic heart diseases administered in India, focusing on streptokinase and finding that it is the life-saving clot-buster for the majority of patients. This brings to light that the surgical intervention of angioplasty is more of an income-biased treatment. Public-funded research and development of indigenous streptokinase has directly enabled access to treatment, especially for economically challenged patients.



 

Subscribers please login to access full text of the article.

 

 

Subscribe Now !

Get instant access to the complete EPW archives

New 3-Month Subscription to Digital Archives at just Rs 450 for India and $18 for overseas users.

  Subscribe  

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top